On this page, you can find presentations from WICH 2025, shared by the presenters who have agreed to make them available.
To access a presentation, please click on its title in the online program below.
| 08:30 – 08:45 | OPENING CEREMONY AND WELCOME TO COUNTRY Chairs: Craig Anderson & Magdy Selim |
| 08:45 – 10:30 | SESSION I – WHERE NEXT FOR MEDICAL TREATMENT? Chairs: David Rodríguez, Chao You |
| 08:45 – 09:10 | Haemostatic therapy, Nikola Sprigg |
| 09:10 – 09:30 | Blood pressure lowering treatment, Xia Wang, Lili Song |
| 09:30 – 09:45 | Expert discussants, Kazunori Toyoda, Timothy Kleinig, Adnan Qureshi |
| 09:45 – 10:00 | Audience discussion |
| 10:00 – 10:30 | Oral Presentations Optimal Magnitude of Blood Pressure Reduction and Hematoma Growth and Functional Outcomes in ICH, Qi Li Stable SBP Reduction as a Therapeutic Goal in ICH: Pooled Analysis of ATACH-2 and INTERACT-2 Trials, Adnan I. Qureshi Remote Ischemic Conditioning for Patients With Supratentorial Intracerebral Hemorrhage (RICH-2), Wenbo Zhao |
| 10:30 – 11:00 | Morning break |
| 11:00 – 12:20 | SESSION II – BASIC SCIENCE, PATHOPHYSIOLOGY, NOVEL THERAPIES Chairs: Richard Keep, Adrian Parry-Jones |
| 11:00 – 11:20 | Expert Overview, Richard Keep |
| 11:20 – 11:40 | Expert discussant, Adrian Parry-Jones, Nikola Sprigg |
| 11:40 – 12:00 | Audience discussion |
| 12:00 – 12:20 | Oral Presentations Desmopressin for reversal of Antiplatelet drugs in Stroke due to intracerebral Haemorrhage (DASH-2), Nikola Sprigg Complement cascade shapes early inflammatory and phagocytic homeostasis in intracerebral hemorrhage, Fan Xia |
| 12:20 – 13:30 | Lunch |
| 12:45 – 13:30 | POSTER SESSION I |
| 13:30 – 15:00 | SESSION III – EAST MEETS WEST FOR SURGICAL TREATMENT Chairs: Xunming Ji, Gao Chen |
| 13:30 – 13:45 | Minimally invasive surgery in China, Zhenchun Liu, Xia Wang |
| 13:45 – 14:00 | Minimally invasive surgery outside China, Karin Klijn |
14:00 – 14:10 | Minimally invasive surgery in Australia, Amal Abou-Hamden |
14:10 – 14:20 | RAINBOW-ICH: a multicentre, RAndomIsed, coNtrolled, umBrella trial fOr minimally invasive neurosurgery With AI-assisted robotic guIdanCe for Haemorrhagic stroke, Xiaobo Yu |
| 14:20 – 14:30 | Discussion |
| 14:30 – 15:00 | Oral Presentations Association Between Hematoma Evacuation and Ischemic Events: A MISTIE III and ATACH-2 Analysis, Wendy Ziai Minimally Invasive Surgery for Deep and Lobar Intracranial Hemorrhages: 180-day MIND study results, Christopher Kellner Comparison of Minimally Invasive Surgery Treatments for Hypertension Intracerebral Hemorrhage, Yuanwei Li |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION V – DIRECTIONS FOR PRE-HOSPITAL MANAGEMENT Chairs: Thorsten Steiner, Carlos Molina |
| 15:30 – 15:45 | GFAP and clinical prediction, Cheryl Carcel |
| 15:45 – 16:00 | Novel imaging and devices,Geoffrey Donnan |
| 16:00 – 16:15 | Ambulance pathways and management, David Paterson |
| 16:15 – 16:30 | Discussion |
| 16:30 – 17:00 | Oral Presentations Pre-hospital blood pressure variability in intracerebral hemorrhage on a Mobile Stroke Unit, Chloe Mutimer Impact of Direct Transfer of ICH to the Angiosuite on BP and Anticoagulation Reversal Time Metrics, David Rodriguez-Luna |
| 17:00 | Finish |
| 18:30 – 21:30 | WELCOME RECEPTION |
| 10:30 – 11:00 | Morning break |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | POSTER SESSION I |
| 13:30 – 15:00 | SESSION IV – ISSUES OF REHABILITATION AND RECOVERY Chairs: Sylaja PN, Michael Pollack |
| 13:30 – 13:45 | Early mobilisation, Emily Ramage |
| 13:45 – 14:00 | Cognition and dementia, Hsin-Hsi (Cynthia) Tsai |
| 14:00 – 14:10 | Management of complications, Michael Pollack |
| 14:10 – 14:30 | Discussion |
| 14:30 – 15:00 | Oral Presentations Intracerebral hemorrhage intelligent staging based on a symptom-time extracted large language model, Xiaochao Luo Quality of Functional Outcome and its determinants in ICH. Insights from the INTERACT3 trial, Carlos Delfino |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION VI – TRENDS IN EPIDEMIOLOGY AND OUTCOMES Chairs: Octavio Pontes Neto, Sylaja PN |
| 15:30 – 15:45 | Burden of disease – Vasileios-Arsenois Lioutas |
| 15:45 – 16:00 | Recovery patterns – Octavio Pontes Neto |
| 16:00 – 16:15 | Management in low-resource settings – Sylaja PN |
| 16:15 – 16:30 | Discussion |
| 16:30 – 17:00 | Oral Presentations Burden of Stroke and Risk Factors in China: an Analysis of the Global Burden of Disease Study 2021, Siyu Yan Impact of socioeconomic status on functional outcome after stroke in Ulaanbaatar, Mongolia, Yijie Gao |
| 17:00 | Finish |
| 18:30 – 21:30 | WELCOME RECEPTION |
| 08:30 – 09:00 | THE JULIAN T HOFF AWARD & WICH EXECUTIVE BOARD SUMMARY |
| 09:00 – 10:30 | SESSION VII – MANAGEMENT OF ANTICOAGULATION-RELATED CEREBRAL HAEMORRHAGE Chairs: Adnan Qureshi, Andrea Morotti |
| 09:00 – 09:20 | Expert Overview, David Seiffge |
| 09:20 – 09:40 | Expert discussants, Andrea Morotti, Geoffrey Donnan |
| 09:40 – 10:00 | Audience discussion |
| 10:00 – 10:10 | ICH ADAPT II trial, Ken Butcher |
| 10:10 – 10:30 | Oral Presentations Early Intensive Blood Pressure Control in Intracerebral Hemorrhage during Antithrombotic Use, Menglu Ouyang |
| 10:30 – 11:00 | Morning break |
| 11:00 – 12:30 | SESSION VIII – CARE BUNDLE PROTOCOLS AND NURSING CARE Chairs: Thorsten Steiner, Trine Apostolaki-Hansson |
| 11:00 – 11:20 | Expert Overview, Teresa Ullberg |
| 11:20 – 11:40 | Expert discussants, Menglu Ouyang, Adrian Parry-Jones, Geoffrey Donnan |
| 11:40 – 12:00 | Audience discussion |
| 12:00 – 12:30 | Oral Presentations Ethnic Disparities in Early Do-Not-Attempt-Resuscitation Orders Following ICH: A Prospective Study, Zhe Kang Law Time-Dependent Association of SBP Fluctuations with Outcomes in ICH: Post Hoc ATACH-2 Analysis, Adnan I. Qureshi Systolic blood pressure trajectory and outcomes in acute intracerebral haemorrhage, Xia Wang |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | POSTER SESSION II |
| 13:30 – 15:00 | SESSION IX – DEVELOPMENTS IN MANAGEMENT OF SAH, AVM AND STRUCTURAL CAUSES OF BRAIN HEMORRHAGE Chairs: You Chao, Amal Abou-Hamden |
| 13:30 – 13:50 | Management of SAH,Amal Abou-Hamden |
| 13:50 – 14:10 | Management of AVMs, Marcus Stoodley |
| 14:10 – 14:40 | Discussion |
| 14:40 – 15:00 | Oral Presentations Correlation between complement activation and early brain injury in human subarachnoid hemorrhage, Richard Keep Comparison of Long‑Term Outcomes in Ruptured Diffuse Brain Arteriovenous Malformations Between Interventional Therapy and Conservative Management, Changyu Lu |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION XI – SECONDARY PREVENTION Chairs: Xiaoying Chen, Sheila Martins |
| 15:30 – 15:50 | Blood pressure control, Anthony Rodgers |
| 15:50 – 16:10 | Antithrombotic treatment, Xin Cheng |
| 16:10 – 16:30 | Combination strategies, Sheila Martins |
| 16:30 – 17:00 | Oral Presentations Update on the Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT), Natalie Espinosa Interim Result of MOBILE Health Intervention after Intracerebral Hemorrhage, Kay Cheong Teo |
| 17:00 – 17:15 | Closing |
| 10:30 – 11:00 | Morning break |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | POSTER SESSION II |
| 13:30 – 15:00 | SESSION X – DIAGNOSIS AND TREATMENT OF CEREBRAL SMALL VESSEL DISEASE AND CEREBRAL AMYLOID ANGIOPATHY Chairs: Hsin-Hsi (Cynthia) Tsai, Floris Schreuder |
| 13:30 – 13:50 | Diagnosis, Floris Schreuder |
| 13:50 – 14:10 | Advancing medical management, Hsin-Hsi (Cynthia) Tsai |
| 14:10 – 14:40 | Outcome prediction, Xin Cheng |
| 14:40 – 15:00 | Oral Presentations The probability of cerebral amyloid angiopathy in lobar intracerebral hemorrhage on head CT, Trine Apostolaki-Hansson CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial, Tien Meng Cheong |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION XII – PROGNOSTIC ALGORITHMS Chairs: Wendy Ziai, Xia Wang |
| 15:30 – 15:50 | Imaging markers, Bernard Yan |
| 15:50 – 16:10 | NeuroICU care, Wendy Ziai |
| 16:10 – 16:30 | Defining patient responder groups, Andrea Morotti |
| 16:30 – 17:00 | Oral Presentations The association between location-specific pre-scan hematoma growth and hematoma expansion, Kay Cheong Teo Are hematoma Hounsfield Units a quantitative marker of growth in intracerebral hemorrhage?, Chloe Mutimer |
| 17:00 | Finish |